Prostate cancer has recently been recognized as a genomically heterogeneous disease with subtypes similar to breast or ovarian cancers.  Read more read more →

Delivering radiation in a shorter time frame significantly reduced the chance of prostate cancer returning in men with an intermediate-risk form of the disease, a study found. Read more read more →

Using the Prostate Health Index test to help diagnose prostate cancer significantly reduces unnecessary and expensive biopsies, a study reports. Read more  read more →

Researchers at the University of Michigan, Ann Arbor may have found the reason why in prostate cancer metastasis, the body’s own immune system helps the cancer to spread. The findings may lead to new drug targets and therapies. Read more read more →

William Oh, MD, chief, Division of Hematology and Medical Oncology, professor of medicine and urology, Mount Sinai School of Medicine, discusses the management of patients with hormone-sensitive prostate cancer. Read more read more →

LOUISVILLE, Ky. (WHAS11) – Dr. Greg Steinbock is a urologist with over 30 years of experience treating prostate cancer. He is currently the co-director of research at First Urology, specializing in urologic and prostate cancer research. Read more  read more →

As part of our coverage of the European Society for Medical Oncology (ESMO) 2017 Congress, we spoke with Claire Vale, PhD, a senior research scientist within the MRC Clinical Trials Unit and a member of the faculty of population health sciences at University College London in the United Kingdom. Dr. Vale presented a late-breaking abstract.. read more →

A study to develop “tailored treatments” for prostate cancer sufferers is being led by researchers at the University of Glasgow. Read more read more →

METHUEN — Just as sure as we will receive our tax bill and see the ball drop on New Year’s Eve every year, men around the country will get screened for prostate cancer at some point during middle age. Read more read more →

A highly precise type of radiotherapy called intensity-modulated radiation therapy (IMRT) may be a safer form of treating lymph nodes in patients with prostate cancer, a clinical trial report suggests. Read more read more →